Birchview Capital, LP Lexicon Pharmaceuticals, Inc. Transaction History

Birchview Capital, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$1.8 - $4.28 $144,000 - $342,400	-80,000 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$4.36 - $7.94 $261,600 - $476,400	60,000 Added 300.0%	80,000 $445,000
Q4 2018 Feb 06, 2019	BUY	$6.15 - $10.51 $123,000 - $210,200	20,000 New	20,000 $133,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Birchview Capital, LP with notifications on news.